Results 1 to 10 of about 165,449 (388)

Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. The VANISH Randomized Clinical Trial [PDF]

Journal of the American Medical Association (JAMA), 2016
IMPORTANCE: Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative.
Andrews, P, Anjum, A, Anjum, A, Ashby, D, Ashby, D, Ashby, D, Aya, HD, Banach, D, Bangalan, J, Banks, F, Bassford, C, Beale, R, Bellingan, G, Bewley, J, Birch, S, Bland, M, Bolger, C, Brett, S, Brett, S, Brett, SJ, Brown, A, Bullock, L, Carungcong, J, Cecconi, M, Cecconi, M, Cepkova, M, Cepkova, M, Chan, K, COLLABORATORS, Collier, T, Correia, C, Creary, T, Cross, M, Das, N, Di Tomasso, N, Ebm, C, Errington, E, Frazier, G, Frazier, GJ, Gladas, K, Golder, K, Gordon, A, Gordon, A, Gordon, AC, Gould, T, Griffiths, S, Grimmer, L, Handy, J, Harris, CL, Harrison-Briggs, D, Hauer, V, Hopkins, P, Hurst, T, Iannucceli, F, Jaques, N, Joscak, J, Kirwan, CJ, Kitson, D, Krige, A, Lamb, N, Lei, K, Mason, A, Mason, AJ, Matthew-Thomas, R, McAuley, D, Mellinghoff, J, Mouland, J, Ochelli-Okpue, A, Ostermann, M, Pahary, SM, Perkins, G, Perkins, GD, Pogson, D, Pogson, DG, Prowle, JR, Pulletz, M, Rose, S, Salmon, K, Santhakumaran, S, Santhakumaran, S, Scott, M, Shah, S, Shankar-Hari, M, Skinner, B, Smith, J, Snow, L, Stapleton, C, Stotz, M, Sweet, K, Tamm, T, Templeton, M, Thirunavukkarasu, N, Thirunavukkarasu, N, Ting, J, VANISH Investigators, Vickers, E, Wade-Smith, F, Walden, A, Ward, G, Warwick, J, Watts, T, Wilkinson, K, Williams, S   +102 more
core   +7 more sources

Vasopressin and its analogues in shock states: a review

Annals of Intensive Care, 2020
Activation of arginine–vasopressin is one of the hormonal responses to face vasodilation-related hypotension. Released from the post-pituitary gland, vasopressin induces vasoconstriction through the activation of V1a receptors located on vascular smooth ...
Julien Demiselle, Nicolas Fage, Peter Radermacher, Pierre Asfar   +3 more
doaj   +2 more sources

Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill Children [PDF]

Children
Background: Intravenous arginine vasopressin is increasingly used for the treatment of critically ill children. It bears the risk of hyponatraemia with potential severe long-term sequelae, but data on hyponatraemia as a side effect of continuous ...
Rafael Muff, Verena Gotta, Vera Jaeggi, Luregn J. Schlapbach, Philipp Baumann   +4 more
doaj   +2 more sources

Pharmacokinetic and pharmacodynamic evaluation of various vasopressin doses and routes of administration in a neonatal piglet model [PDF]

Scientific Reports
Epinephrine is the only recommended vasopressor during neonatal cardiopulmonary resuscitation. However, there are concerns about the potential adverse effects of epinephrine, which might hamper efficacy during cardiopulmonary resuscitation.
Marwa Ramsie, Po-Yin Cheung, Megan O’Reilly, Tze-Fun Lee, Georg M. Schmölzer   +4 more
doaj   +2 more sources

Hemodynamic Management with Vasopressin for Cardiovascular Surgery [PDF]

Medicina
Background and Objectives: Vasopressin increases blood pressure through aquaporin-2-mediated water retention and is useful for managing hemodynamics after surgery.
Hideyuki Kato, Bryan J. Mathis, Tomonari Shimoda, Tomomi Nakajima, Chiho Tokunaga, Yuji Hiramatsu   +5 more
doaj   +2 more sources

The Association Between Vasopressin and Adverse Kidney Outcomes in Children and Young Adults Requiring Vasopressors on Continuous Renal Replacement Therapy [PDF]

Critical Care Explorations
OBJECTIVES:. Continuous renal replacement therapy (CRRT) and shock are both associated with high morbidity and mortality in the ICU. Adult data suggest renoprotective effects of vasopressin vs. catecholamines (norepinephrine and epinephrine). We aimed to
Denise C. Hasson, MD, Katja M. Gist, DO, MSc, JangDong Seo, PhD, Erin K. Stenson, MD, Aaron Kessel, MD, MS, Taiki Haga, MD, MSc, Sara LaFever, MD, PhD, Maria Jose Santiago, MD, PhD, Matthew Barhight, MD, MS, David Selewski, MD, MSCR, Zaccaria Ricci, MD, Nicholas J. Ollberding, PhD, Natalja L. Stanski, MD, on behalf of the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) Collaborative, Emily Ahern, CPNP, DNP, Ayse Akcan Arikan, MD, Issa Alhamoud, MD, Rashid Alobaidi, MD, MSc, Pilar Anton-Martin, MD, PhD, Shanthi S. Balani, MD, Matthew Barhight, MD, MS, Abby Basalely, MD, MS, Amee M. Bigelow, MD, MS, Gabriella Bottari, MD, Andrea Cappoli, MD, Eileen A. Ciccia, MD, Michaela Collins, BA, Denise Colosimo, MD, Gerard Cortina, MD, Mihaela A. Damian, MD, MPH, Sara De la Mata Navazo, MD, Gabrielle DeAbreu, MD, Akash Deep, MD, Kathy L. Ding, BS, Kristin J. Dolan, MD, Sarah N. Fernandez Lafever, MD, PhD, Dana Y. Fuhrman, DO, MS, Ben Gelbart, MBBS, Katja M. Gist, DO, MSc, Stephen M. Gorga, MD, MSc, Francesco Guzzi, MD, Isabella Guzzo, MD, Taiki Haga, MD, Elizabeth Harvey, MD, Denise C. Hasson, MD, Taylor Hill-Horowitz, BS, Haleigh Inthavong, BS, MS, Catherine Joseph, MD, Ahmad Kaddourah, MD, MS, Aadil Kakajiwala, MD, MSCI, Aaron D. Kessel, MD, MS, Sarah Korn, DO, Kelli A. Krallman, BSN, MS, David M. Kwiatkowski, MD, Msc, Jasmine Lee, MSc, Laurance Lequier, MD, Tina Madani Kia, BS, Kenneth E. Mah, MD, MS, Eleonora Marinari, MD, Susan D. Martin, MD, Shina Menon, MD, Tahagod H. Mohamed, MD, Catherine Morgan, MD, MSc, Theresa A. Mottes, APRN, Melissa A. Muff-Luett, MD, Siva Namachivayam, MBBS, Tara M. Neumayr, MD, Jennifer Nhan Md, MS, Abigail O’Rourke, MD, Nicholas J. Ollberding, PhD, Matthew G. Pinto, MD, Dua Qutob, MD, Valeria Raggi, MD, Stephanie Reynaud, MD, Zaccaria Ricci, MD, Zachary A. Rumlow, DO, María J. Santiago Lozano, MD, PhD, Emily See, MBBS, David T. Selewski, MD, MSCR, Carmela Serpe, MSc, PhD, Alyssa Serratore, RN, MsC, Ananya Shah, BS, Weiwen V. Shih, MD, H. Stella Shin, MD, Cara L. Slagle, MD, Sonia Solomon, DO, Danielle E. Soranno, MD, Rachana Srivastava, MD, Natalja L. Stanski, MD, Michelle C. Starr, MD, MPH, Erin K. Stenson, MD, Amy E. Strong, MD, MSCE, Susan A. Taylor, MSc, Sameer V. Thadani, MD, Amanda M. Uber, DO, Brynna Van Wyk, ARNP, MSN, Tennille N. Webb, MD, MSPH, Huaiyu Zang, PhD, Emily E. Zangla, DO, Michael Zappitelli, MD, MSc, T. Christine, E. Alvarez, MHI, RN, Elizabeth Bixler, BS, Erica Blender Brown, MA, CRA, Cheryl L. Brown, BS, Ambra Burrell, BA, Anwesh Dash, BS, Jennifer L. Ehrlich, RN, MHA, Simrandeep Farma, HBSc, Kim Gahring, RN, BSN, CCRN, Barbara Gales, RN, Madison R. Hilgenkamp, Sonal Jain, MS, Kate Kanwar, BA, MS, Jennifer Lusk, BSN, RN, CCRN, Christopher J. Meyer, BA AA, Katherine Plomaritas, BSN, RN, Joshua Porter, BS, Jessica Potts, BSN, RN, Alyssa Serratore, BNurs, GDipNP(PIC), RN, MsC, Elizabeth Schneider, BS, Vidushi Sinha, BS, P. J. Strack, RN, BSN, CCRN, Sue Taylor, RN, Katherine Twombley, MD, Brynna Van Wyk, MSN, ARNP, CPNP, Samantha Wallace, MS, Janet Wang, BS, Megan Woods, BS, Marcia Zinger, RN, Alison Zong, BS   +130 more
doaj   +2 more sources

Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit [PDF]

Frontiers in Pediatrics
ObjectivesVasopressin is used for shock and acute pulmonary hypertension in the neonatal intensive care unit (NICU) and is associated with hyponatremia.
Kavita Patel, Sharon Thomson, Meera Vijayan, Marjorie Makoni, Peter N. Johnson, Katy Stephens, Stephen B. Neely, Jamie L. Miller   +7 more
doaj   +2 more sources

Oxytocin, vasopressin, and social behavior: from neural circuits to clinical opportunities.

Endocrinology, 2022
Oxytocin and vasopressin are peptide hormones secreted from the pituitary that are well known for their peripheral endocrine effects on childbirth/nursing and blood pressure/urine concentration, respectively.
Nicole Rigney, G. J. de Vries, A. Petrulis, L. Young   +3 more
semanticscholar   +1 more source

α-Actinin 4 Links Vasopressin Short-Term and Long-Term Regulation of Aquaporin-2 in Kidney Collecting Duct Cells

Frontiers in Physiology, 2021
Water permeability of the kidney collecting ducts is regulated by the peptide hormone vasopressin. Between minutes and hours (short-term), vasopressin induces trafficking of the water channel protein aquaporin-2 to the apical plasma membrane of the ...
Cheng-Hsuan Ho, Hsiu-Hui Yang, Shih-Han Su, Ai-Hsin Yeh, Ming-Jiun Yu   +4 more
doaj   +1 more source

Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock. [PDF]

PLoS ONE, 2015
Current research suggests that administration of vasopressin to patients with uncontrolled hemorrhagic shock (UHS) can avoid the detrimental effects associated with aggressive fluid resuscitation.
Meng-Tse Gabriel Lee, Hsuan-Mao Wang, Ja-An Annie Ho, Nien-Chu Fan, Ya-Lin Yang, Chien-Chang Lee, Shyr-Chyr Chen   +6 more
doaj   +1 more source